OrigiMed
Latest round
- Series B
Last raised
- Nov 2018
Total raised
- $10M
Investors
- 5
About OrigiMed
Established in 2016 and based in Shanghai, China, OrigiMed operates and develops detecting techniques to detect any abnormal genetic information for cancer. It also provides medical counseling service for patients.
Who invested in OrigiMed
5 investors across 3 rounds
See all investors in OrigiMed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about OrigiMed
Who invested in OrigiMed?
OrigiMed has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has OrigiMed raised?
OrigiMed has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did OrigiMed last raise money?
OrigiMed's most recent round on record is a Series B, in Nov 2018.
What does OrigiMed do?
Established in 2016 and based in Shanghai, China, OrigiMed operates and develops detecting techniques to detect any abnormal genetic information for cancer.
Where is OrigiMed headquartered?
OrigiMed is headquartered in Shanghai, China.
Which VCs invest in companies like OrigiMed?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at OrigiMed's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like OrigiMed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.